Physician
Vivek Mittal, M.D. and Manisha Mittal, M.D. INC.
Vivek Mittal, M.D. and Manisha Mittal, M.D. INC. was paid $591K by Medicaid between Jan 2018 and Nov 2024, across 31 billing codes. Its largest line is J2507, Injection, pegloticase, 1 mg — 30% of everything it billed.
33Billing provider infoVIVEK MITTAL, M.D. AND MANISHA MITTAL, M.D. INC.
FRESNO, CA 93720
FRESNO, CA 93720
33aNPI1194253872assigned 05/25/2017
33bProvider typeGastroenterology Physician
28Total paid$591K
24GClaims33,729
24DCodes billed31
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Gastroenterology Physician providers in California
Rank by total paid#73 of 363
Median peer was paid$55K
This provider vs. median11×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 470 | $13K | |
| 2019 | 1,677 | $17K | |
| 2020 | 2,940 | $29K | |
| 2021 | 4,341 | $41K | |
| 2022 | 9,192 | $147K | |
| 2023 | 8,798 | $281K | |
| 2024incomplete | 6,311 | $63K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J2507 | Injection, pegloticase, 1 mg | 30% | 73 | 49 | $180K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 13% | 812 | 732 | $75K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 9.0% | 323 | 317 | $53K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 8.2% | 3,177 | 3,164 | $48K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 5.9% | 1,104 | 1,097 | $35K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 5.6% | 1,209 | 1,206 | $33K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 5.3% | 7,273 | 7,048 | $31K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 4.7% | 2,412 | 2,409 | $28K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 4.3% | 7,189 | 6,947 | $26K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 4.1% | 2,446 | 2,441 | $24K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 3.6% | 1,491 | 1,289 | $21K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 2.4% | 342 | 338 | $14K |
19 more codes
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 1.8% | 357 | $10K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | 1.0% | 855 | $6K |
| 99243 | <1% | 513 | $1K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,181 | $1K |
| 96401 | <1% | 586 | $1K | |
| 96415 | <1% | 447 | $955.23 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 593 | $455.77 |
| J0490 | Injection, belimumab, 10 mg | <1% | 102 | $422.94 |
| 99152 | <1% | 238 | $351.45 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 178 | $225.00 |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 247 | $192.70 |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 56 | $102.20 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 174 | $73.51 |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 79 | $0.00 |
| 99153 | Mod sedat endo service >5yrs | 0% | 12 | $0.00 |
| 4040F | 0% | 73 | $0.00 | |
| G8421 | Bmi not documented and no reason is given | 0% | 42 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 102 | $0.00 |
| G8482 | Influenza immunization administered or previously received | 0% | 43 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMITTAL, VIVEK (PRESIDENT)